ArticleAdvances in therapy2020

24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL Study.

David A Lipson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.